A detailed history of Black Rock Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Black Rock Inc. holds 142,959,104 shares of ABBV stock, worth $23.8 Billion. This represents 0.61% of its overall portfolio holdings.

Number of Shares
142,959,104
Previous 143,182,709 0.16%
Holding current value
$23.8 Billion
Previous $22.2 Billion 17.32%
% of portfolio
0.61%
Previous 0.57%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $35.7 Million - $40.7 Million
-223,605 Reduced 0.16%
142,959,104 $26 Billion
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $711 Million - $801 Million
5,165,853 Added 3.74%
143,182,709 $22.2 Billion
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $153 Million - $177 Million
-1,144,940 Reduced 0.82%
138,016,856 $20.6 Billion
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $58.3 Million - $72.6 Million
440,286 Added 0.32%
139,161,796 $18.7 Billion
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $2.71 Million - $3.12 Million
18,752 Added 0.01%
138,721,510 $22.1 Billion
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $794 Million - $953 Million
5,742,609 Added 4.32%
138,702,758 $22.4 Billion
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $234 Million - $268 Million
-1,740,499 Reduced 1.29%
132,960,149 $17.8 Billion
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $698 Million - $887 Million
5,069,770 Added 3.91%
134,700,648 $20.6 Billion
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $189 Million - $235 Million
1,433,324 Added 1.12%
129,630,878 $21 Billion
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $146 Million - $185 Million
1,358,115 Added 1.07%
128,197,554 $17.4 Billion
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $452 Million - $513 Million
4,247,445 Added 3.46%
126,839,439 $13.7 Billion
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $12.9 Billion - $14.4 Billion
122,591,994 New
122,591,994 $13.8 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.